Cancer Related Gene Mutation Detection Suppliers & Manufacturers

20/20 GeneSystems Inc. develops and commercializes diagnostic tests for the early detection of cancer to improve outcomes of people at high risk for specific types of cancers. It offers blood tests for use in the United States to aid in the early ...

Imaging Diagnostic Systems, Inc. (IDSI) is a medical device company headquartered in Florida, specializing in the research, development, and marketing of innovative cancer detection systems. Their flagship product, the CTLM system (Computed ...

Founded in 2016, CatchGene Co., Ltd. groups experts from different fields, including molecular biology, electrical engineering, software engineering and mechanics. We are dedicating to develop a better solution for purifying rare cfDNA or cfRNA from ...

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based epigenetics, our pioneering testing approach uses ...

Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...

Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the ...

Avelas is a clinical-stage drug-device company pioneering the field of fluorescence imaging for real-time cancer detection. Avelas is focused on the development and commercialization of pegloprastide (also referred to as “AVB-620”), a novel ...

Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...

OTraces, Inc. has built, and extensively filed patents protection on, an early tumor detection and cancer screening software technology. Technology uses well-known math- and physics-based A-I methods including those used in advanced satellite ...

At Kheiron, we believe that by combining human intelligence with the power of AI, we can help transform cancer diagnostics. Detecting cancer and tracking it accurately is challenging and time-consuming for even the most experienced radiologists. ...

VisionGate, Inc., is a breakthrough liquid-biopsy technology company, leading the battle against lung cancer through early detection technology with a simple, non-intrusive sputum test. The foundation for our diagnostics capability is the ...

Hybribio, a leader in molecular diagnostic products in China, is engaged in the nucleic acid diagnostic field. It provides a full operation chain from research and development to production and sales. The company's capabilities are enriched by an ...

Advances in cancer diagnostics have enabled the detection of cancer at its earliest stages when the chances for successful intervention are highest. For many tumors, surgery offers the best option for a cure, with the potential to remove all cancer ...

We develop and commercialize patented, disruptive liquid biopsy tests – innovative blood tests in oncology – based on a unique cell isolation technology called ISET (Isolation by SizE of Tumor cells) and cyto-molecular profiling of Circulating Tumor ...

At Aindra, we are building a world where Clinical Pathology is Data driven, Fast and Patient focused. Aindra Systems, our goal is to democratise access to quality healthcare, by using deep technology to realise our vision of accessible and ...

At Check-Cap our experienced and motivated team is committed to increasing screening adherence and helping to reduce the global incidence of colorectal cancer (CRC) through cancer prevention. Our patented technology C-Scan is the first and only ...

Lightpoint Medical is a technology leader in targeted cancer surgery. We are developing miniaturized imaging and sensing tools for more precise intra-operative cancer detection. Our mission is to improve the lives of people with cancer by ...

BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...

We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...

Da Zen Theranostics, Inc. (Da Zen) has developed revolutionary therapies for cancer detection, imaging, and treatment in order to prolong survival and improve quality of life for patients with cancer. The innovative research at Da Zen has led to the ...